We are live on ! Find out more
AURA icon

Aura Biosciences
AURA

43 hedge funds and large institutions have $296M invested in Aura Biosciences in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 24 increasing their positions, 9 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 9

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

32% more capital invested

Capital invested by funds: $224M → $296M (+$71.9M)

1.77% more ownership

Funds ownership: 53.98% → 55.75% (+1.8%)

2% less funds holding

Funds holding: 44 → 43 (-1)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

Holders
43
Holders Change
-1
Holders Change %
-2.27%
% of All Funds
0.74%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
2
Increased
24
Reduced
9
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$2.64M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$2.58M
3
BlackRock
BlackRock
New York
+$1.92M
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$1.24M
5
State Street
State Street
Massachusetts
+$631K

Top Sellers

Rank Fund Capital Flow
1
UOC
UBS O'Connor
Illinois
-$1.18M
2
Allianz Asset Management
Allianz Asset Management
Germany
-$873K
3
RCM
Regency Capital Management
Hawaii
-$455K
4
Millennium Management
Millennium Management
New York
-$325K
5
UBS Group
UBS Group
Switzerland
-$61.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
MCMC
1
Matrix Capital Management Company
New Hampshire
$74.5M – – –
MVM
2
Medicxi Ventures Management
Jersey
$55.1M – – –
Citadel Advisors
3
Citadel Advisors
Florida
$41.9M +$2.41K +159 +0%
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$26.3M +$2.64M +174,582 +14%
RSCM
5
Rock Springs Capital Management
Maryland
$18.4M +$105K +6,943 +0.7%
BlackRock
6
BlackRock
New York
$18.4M +$1.92M +126,732 +14%
Vanguard Group
7
Vanguard Group
Pennsylvania
$11M +$2.58M +170,709 +39%
Fidelity Investments
8
Fidelity Investments
Massachusetts
$10.9M +$4.39K +290 +0%
NCM
9
Nantahala Capital Management
Connecticut
$6.95M +$614K +40,549 +12%
State Street
10
State Street
Massachusetts
$5.41M +$631K +41,692 +16%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$5.24M +$1.24M +82,018 +40%
RCM
12
Regency Capital Management
Hawaii
$4.07M -$455K -30,068 -12%
DCMIC
13
Decheng Capital Management III (Cayman)
Cayman Islands
$3.81M – – –
Citigroup
14
Citigroup
New York
$2.71M +$402K +26,552 +22%
Northern Trust
15
Northern Trust
Illinois
$2.63M +$188K +12,409 +9%
N
16
Nuveen
North Carolina
$1.12M +$7.52K +497 +0.8%
Morgan Stanley
17
Morgan Stanley
New York
$1M +$9.28K +613 +1%
Bank of New York Mellon
18
Bank of New York Mellon
New York
$912K +$155K +10,240 +26%
Charles Schwab
19
Charles Schwab
California
$852K +$60.5K +3,994 +9%
Bank of America
20
Bank of America
North Carolina
$820K +$150K +9,896 +28%
Barclays
21
Barclays
United Kingdom
$762K -$2.15K -142 -0.3%
RhumbLine Advisers
22
RhumbLine Advisers
Massachusetts
$405K +$24.6K +1,626 +8%
New York State Common Retirement Fund
23
New York State Common Retirement Fund
New York
$262K +$1.82K +120 +0.8%
CAPTRUST Financial Advisors
24
CAPTRUST Financial Advisors
North Carolina
$243K – – –
UOC
25
UBS O'Connor
Illinois
$225K -$1.18M -78,109 -86%
1
2

AURA Hedge Fund Activity: Q3 2022 in Review

43 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Aura Biosciences (AURA) for Q3 2022, worth a combined $296M — up 32% from $224M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of AURA and 2 opened new positions — a net loss of 1 holder — while 9 trimmed existing stakes and 24 added.

The largest buyer was Adage Capital Partners, adding an estimated $2.64M. The largest seller was UBS O'Connor, cutting an estimated $1.18M.

  • 43 institutional investors held Aura Biosciences (AURA) as of Q3 2022, down from 44 in Q2 2022.
  • Funds reported $296M of Aura Biosciences stock for Q3 2022, up 32% quarter-over-quarter.
  • 2 funds opened new Aura Biosciences positions in Q3 2022 and 3 closed out, a net change of -1 holder.
  • The largest Aura Biosciences buyer in Q3 2022 was Adage Capital Partners, an estimated $2.64M added.
  • The largest Aura Biosciences seller in Q3 2022 was UBS O'Connor, an estimated $1.18M sold.

Based on aggregated 13F filings for Q3 2022.